Immuneering Corp. (IMRX)
5.02
0.00 (0.00%)
USD |
NASDAQ |
Mar 23, 10:44
Immuneering EPS Diluted (Quarterly) : -0.1793 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | -2.389 |
| Verastem, Inc. | -0.3947 |
| Phathom Pharmaceuticals, Inc. | -0.2865 |
| Tango Therapeutics, Inc. | -0.2945 |
| X4 Pharmaceuticals, Inc. | -0.2164 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.58M |
| Total Expenses (Quarterly) | 11.58M |
| Enterprise Value | 155.55M |
| Earnings Yield | -27.51% |
| Normalized Earnings Yield | -27.51 |